Mirion Technologies, Inc. (NYSE:MIR – Get Free Report) shares gapped up before the market opened on Friday . The stock had previously closed at $10.68, but opened at $11.05. Mirion Technologies shares last traded at $10.79, with a volume of 369,860 shares trading hands.
Analyst Ratings Changes
Separately, Citigroup lifted their price target on shares of Mirion Technologies from $13.00 to $14.00 and gave the company a “buy” rating in a research report on Monday, April 8th.
View Our Latest Stock Report on MIR
Mirion Technologies Trading Up 1.1 %
Mirion Technologies (NYSE:MIR – Get Free Report) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $0.05 earnings per share for the quarter. Mirion Technologies had a negative net margin of 9.87% and a positive return on equity of 3.44%. The business had revenue of $192.60 million during the quarter.
Insider Activity
In other news, insider Emmanuelle Lee sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $10.17, for a total value of $50,850.00. Following the completion of the transaction, the insider now owns 138,193 shares of the company’s stock, valued at $1,405,422.81. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, insider Emmanuelle Lee sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $10.17, for a total value of $50,850.00. Following the completion of the transaction, the insider now owns 138,193 shares of the company’s stock, valued at $1,405,422.81. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Thomas D. Logan sold 7,500 shares of Mirion Technologies stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $10.86, for a total transaction of $81,450.00. Following the completion of the transaction, the chief executive officer now owns 1,544,017 shares of the company’s stock, valued at approximately $16,768,024.62. The disclosure for this sale can be found here. Over the last quarter, insiders sold 20,653 shares of company stock valued at $216,194. 2.20% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Central Pacific Bank Trust Division purchased a new position in Mirion Technologies in the first quarter worth approximately $85,000. Bayesian Capital Management LP purchased a new position in Mirion Technologies in the first quarter worth approximately $226,000. Lazard Asset Management LLC lifted its stake in Mirion Technologies by 19.8% in the first quarter. Lazard Asset Management LLC now owns 22,751 shares of the company’s stock worth $258,000 after acquiring an additional 3,753 shares during the last quarter. Victory Capital Management Inc. lifted its position in shares of Mirion Technologies by 22.5% during the 4th quarter. Victory Capital Management Inc. now owns 27,873 shares of the company’s stock worth $286,000 after buying an additional 5,119 shares during the last quarter. Finally, Trexquant Investment LP purchased a new stake in shares of Mirion Technologies during the 4th quarter worth approximately $361,000. Hedge funds and other institutional investors own 78.51% of the company’s stock.
About Mirion Technologies
Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.
Further Reading
- Five stocks we like better than Mirion Technologies
- Bank Stocks – Best Bank Stocks to Invest In
- McDonald’s Stock: Balancing Value and Innovation
- With Risk Tolerance, One Size Does Not Fit All
- MarketBeat Week in Review – 6/17 – 6/21
- Stock Average Calculator
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for Mirion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mirion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.